PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-4.09%
Negative revenue growth while 5715.T stands at 0.79%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
20.02%
Gross profit growth similar to 5715.T's 19.81%. Walter Schloss would assume both firms track common industry trends.
220.05%
EBIT growth above 1.5x 5715.T's 18.90%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
433.12%
Operating income growth above 1.5x 5715.T's 126.95%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
584.80%
Positive net income growth while 5715.T is negative. John Neff might see a big relative performance advantage.
586.19%
Positive EPS growth while 5715.T is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
586.19%
Positive diluted EPS growth while 5715.T is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.00%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.00%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
2.62%
OCF growth above 1.5x 5715.T's 0.10%. David Dodd would confirm a clear edge in underlying cash generation.
2.62%
FCF growth above 1.5x 5715.T's 0.10%. David Dodd would verify if the firm’s strategic investments yield superior returns.
68.20%
10Y revenue/share CAGR above 1.5x 5715.T's 37.64%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
10.27%
5Y revenue/share CAGR under 50% of 5715.T's 30.86%. Michael Burry would suspect a significant competitive gap or product weakness.
2.58%
3Y revenue/share CAGR under 50% of 5715.T's 35.51%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
70.33%
Positive 10Y CAGR while 5715.T is negative. John Neff might see a substantial advantage in bottom-line trajectory.
614.27%
Positive 5Y CAGR while 5715.T is negative. John Neff might view this as a strong mid-term relative advantage.
-27.77%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
355.71%
10Y equity/share CAGR above 1.5x 5715.T's 138.51%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
41.84%
5Y equity/share CAGR above 1.5x 5715.T's 26.00%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
24.87%
3Y equity/share CAGR similar to 5715.T's 27.38%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-9.00%
Firm’s AR is declining while 5715.T shows 2.90%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
10.48%
Inventory growth well above 5715.T's 14.97%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-0.49%
Negative asset growth while 5715.T invests at 2.20%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
3.76%
1.25-1.5x 5715.T's 2.74%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
-8.16%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
7.59%
R&D growth drastically higher vs. 5715.T's 3.26%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
-1.72%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.